Shengguo Xu - Maccura Biotechnology Director Director
| 300463 Stock | 14.01 0.17 1.23% |
Director
Shengguo Xu is Director Director of Maccura Biotechnology Co
| Age | 45 |
| Address | Hi-tech Zone, Chengdu, China, 611730 |
| Phone | 86 28 8173 1888 |
| Web | https://www.maccura.com |
Maccura Biotechnology Management Efficiency
The company has return on total asset (ROA) of 0.0219 % which means that it generated a profit of $0.0219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0485 %, meaning that it generated $0.0485 on every $100 dollars invested by stockholders. Maccura Biotechnology's management efficiency ratios could be used to measure how well Maccura Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Maccura Biotechnology's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 175.1 M, whereas Total Assets are forecasted to decline to about 5.4 B.Similar Executives
| Found 9 records | DIRECTOR Age | ||
| Zhiqi Cai | Vontron Technology Co | 54 | |
| Wen Tu | Gan Yuan Foods | 43 | |
| Jin Gu | Namchow Food Group | 48 | |
| Li Jun | Zhongyin Babi Food | 51 | |
| Jin Bao | Xizi Clean Energy | 35 | |
| Jian Yan | Gan Yuan Foods | 46 | |
| Wukai Zhang | Jiamei Food Packaging | 54 | |
| Zhoujing Chen | Namchow Food Group | N/A | |
| Yan Jin | Vontron Technology Co | 45 | |
Management Performance
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0219 |
Maccura Biotechnology Leadership Team
Elected by the shareholders, the Maccura Biotechnology's board of directors comprises two types of representatives: Maccura Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Maccura. The board's role is to monitor Maccura Biotechnology's management team and ensure that shareholders' interests are well served. Maccura Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Maccura Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shengguo Xu, Director Director | ||
| Wei Shi, Secretary Investment | ||
| Wu Mingjian, GM Director | ||
| Hui Yang, Director Reagents | ||
| Zhen Wang, Production Director | ||
| Ping Yu, Administrative Department | ||
| Shan Yin, CFO Director |
Maccura Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Maccura Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0485 | ||||
| Return On Asset | 0.0219 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.17 % | ||||
| Current Valuation | 8.38 B | ||||
| Shares Outstanding | 612.47 M | ||||
| Shares Owned By Insiders | 40.27 % | ||||
| Shares Owned By Institutions | 4.76 % | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 3.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Maccura Stock
Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.